{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:19:02Z","timestamp":1778253542288,"version":"3.51.4"},"reference-count":47,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2019.10703","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T11:16:42Z","timestamp":1564744602000},"source":"Crossref","is-referenced-by-count":3,"title":["nm23, TOP2A and VEGF expression: Potential prognostic biologic factors in peripheral T\u2011cell lymphoma, not otherwise specified"],"prefix":"10.3892","author":[{"given":"Wenting","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Pathology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linshu","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuyun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,8,2]]},"reference":[{"key":"key20200714091613_b1-ol-0-0-10703","first-page":"1006","article-title":"Peripheral T-cell Lymphoma, Not Otherwise Specified","volume-title":"Diagnostic pathology lymph nodes and spleen with extranodal lymphomas","author":"You","year":"2011"},{"key":"key20200714091613_b2-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/bjh.13586","article-title":"Classification of non-Hodgkin lymphoma in South-eastern Europe: Review of 632 cases from the international non-Hodgkin lymphoma classification project","volume":"171","author":"Dotlic","year":"2015","journal-title":"Br J Haematol"},{"key":"key20200714091613_b3-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12185-014-1520-3","article-title":"Peripheral T cell lymphoma in Asia","volume":"99","author":"Park","year":"2014","journal-title":"Int J Hematol"},{"key":"key20200714091613_b4-ol-0-0-10703","first-page":"403","article-title":"Peripheral T-Cell Lymphoma, NOS","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Pileri","year":"2017"},{"key":"key20200714091613_b5-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12957-017-1279-0","article-title":"Roles of KAI1 and nm23 in lymphangiogenesis and lymph metastasis of laryngeal squamous cell carcinoma","volume":"15","author":"Zheng","year":"2017","journal-title":"World J Surg Oncol"},{"key":"key20200714091613_b6-ol-0-0-10703","first-page":"345","article-title":"Loss of Nm23 is associated with a more favorable tumor microenvironment in patients with breast cancer","volume":"30","author":"Dur\u00e1n","year":"2015","journal-title":"Histol Histopathol"},{"key":"key20200714091613_b7-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.virol.2017.03.014","article-title":"Hepatitis C Virus E1 protein promotes cell migration and invasion by modulating cellular metastasis suppressor Nm23-H1","volume":"506","author":"Khera","year":"2017","journal-title":"Virology"},{"key":"key20200714091613_b8-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"72","DOI":"10.17305\/bjbms.2013.2368","article-title":"Immunohistochemical expression and significance of NM23 suppressor protein in primary gastric adenocarcinoma","volume":"13","author":"Radovi\u0107","year":"2013","journal-title":"Bosn J Basic Med Sci"},{"key":"key20200714091613_b9-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1158\/1078-0432.CCR-10-2999","article-title":"Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma, not otherwise specified","volume":"17","author":"Niitsu","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20200714091613_b10-ol-0-0-10703","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1182\/blood.V94.10.3541.422k15_3541_3550","article-title":"Prognostic implications of the differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma","volume":"94","author":"Niitsu","year":"1999","journal-title":"Blood"},{"key":"key20200714091613_b11-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-03-0085","article-title":"Clinical significance of intracytoplasmic nm23-H1 expression in diffuse large B-cell lymphoma","volume":"10","author":"Niitsu","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20200714091613_b12-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1007\/s10620-017-4718-4","article-title":"overexpression of topoisomerase 2-alpha confers a poor prognosis in pancreatic adenocarcinoma identified by co-expression analysis","volume":"62","author":"Zhou","year":"2017","journal-title":"Dig Dis Sci"},{"key":"key20200714091613_b13-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"265.e1","DOI":"10.1016\/j.urology.2016.12.050","article-title":"TOP2A, HELLS, ATAD2, and TET3 are novel prognostic markers in renal cell carcinoma","volume":"102","author":"Chen","year":"2017","journal-title":"Urology"},{"key":"key20200714091613_b14-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/IGC.0000000000000607","article-title":"Evaluation of TOP2A as a predictive marker for endometrial cancer with Taxane-containing adjuvant chemotherapy","volume":"26","author":"Ito","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"key20200714091613_b15-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/PAI.0000000000000154","article-title":"The predictive and prognostic role of topoisomerase II\u03b1 and tissue inhibitor of metalloproteinases 1 expression in locally advanced breast carcinoma of egyptian patients treated with anthracycline-based neoadjuvant chemotherapy","volume":"24","author":"El Rebey","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"key20200714091613_b16-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00428-010-0922-8","article-title":"A novel quantitative PCR of proliferation markers (Ki-67, topoisomerase IIalpha and TPX2): An immunohistochemical correlation, testing, and optimizing for mantle cell lymphoma","volume":"456","author":"Brizova","year":"2010","journal-title":"Virchows Arch"},{"key":"key20200714091613_b17-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"key20200714091613_b18-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.7150\/jca.17358","article-title":"IRF4\/MUM1 expression is associated with poor survival outcomes in patients with peripheral T-cell lymphoma","volume":"8","author":"Heo","year":"2017","journal-title":"J Cancer"},{"key":"key20200714091613_b19-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature09002","article-title":"Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis","volume":"465","author":"Wang","year":"2010","journal-title":"Nature"},{"key":"key20200714091613_b20-ol-0-0-10703","first-page":"729725","article-title":"Vascular endothelial growth factor-related pathways in hemato-lymphoid malignancies","author":"Medinger","year":"2010","journal-title":"J Oncol 2010"},{"key":"key20200714091613_b21-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1097\/PAS.0b013e31828b6ad3","article-title":"Prognostic significance of COX-2 expression and correlation with Bcl-2 and VEGF expression, microvessel density and clinical variables in classical Hodgkin lymphoma","volume":"37","author":"Koh","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"key20200714091613_b22-ol-0-0-10703","first-page":"786790","article-title":"VEGF overexpression is a valuable prognostic factor for non-Hodgkin's lymphoma evidence from a systemic meta-analysis","author":"Yang","year":"2015","journal-title":"Dis Markers 2015"},{"key":"key20200714091613_b23-ol-0-0-10703","first-page":"1860","article-title":"Report of the committee on Hodgkin's disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"key20200714091613_b24-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","author":"International Non-Hodgkin's Lymphoma Prognostic Factors","year":"1993","journal-title":"N Engl J Med"},{"key":"key20200714091613_b25-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1111\/bjd.15720","article-title":"Vascular endothelial growth factor protein expression is associated with a poor prognosis in patients with cutaneous extranodal natural killer\/T-cell lymphoma","volume":"178","author":"Lee","year":"2018","journal-title":"Br J Dermatol"},{"key":"key20200714091613_b26-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"851","DOI":"10.7150\/jca.23039","article-title":"Cancer survival in patients from a hospital-based cancer registry, China","volume":"9","author":"Chen","year":"2018","journal-title":"J Cancer"},{"key":"key20200714091613_b27-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.avsg.2015.08.016","article-title":"Costs of Real-life endovascular treatment of critical limb ischemia: Report from Poland-A European union country with a low-budget health care system","volume":"31","author":"Krzanowski","year":"2016","journal-title":"Ann Vasc Surg"},{"key":"key20200714091613_b28-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11899-010-0062-x","article-title":"Prognostic markers in peripheral T-cell lymphoma","volume":"5","author":"Piccaluga","year":"2010","journal-title":"Curr Hematol Malig Rep"},{"key":"key20200714091613_b29-ol-0-0-10703","first-page":"905","article-title":"Peripheral T-cell lymphoma, not otherwise specified: A retrospective single-center analysis","volume":"58","author":"Suzuki","year":"2017","journal-title":"Rinsho Ketsueki"},{"key":"key20200714091613_b30-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00277-008-0544-2","article-title":"Clinical features and prognostic factors of patients with \u2018peripheral T cell lymphoma, unspecified\u2019","volume":"88","author":"Lee","year":"2009","journal-title":"Ann Hematol"},{"key":"key20200714091613_b31-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): A new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"key20200714091613_b32-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1746-1596-6-77","article-title":"Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution","volume":"6","author":"Yang","year":"2011","journal-title":"Diagn Pathol"},{"key":"key20200714091613_b33-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: Pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20200714091613_b34-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/bjh.15258","article-title":"Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network","volume":"181","author":"Federico","year":"2018","journal-title":"Br J Haematol"},{"key":"key20200714091613_b35-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/bjh.14477","article-title":"The survival outcome of patients with relapsed\/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma","volume":"176","author":"Chihara","year":"2017","journal-title":"Br J Haematol"},{"key":"key20200714091613_b36-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1200\/JCO.2012.44.7524","article-title":"Survival of patients with peripheral T-cell lymphoma after first relapse or progression: Spectrum of disease and rare long-term survivors","volume":"31","author":"Mak","year":"2013","journal-title":"J Clin Oncol"},{"key":"key20200714091613_b37-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: A report of 340 cases from the International Peripheral T-cell Lymphoma Project","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"key":"key20200714091613_b38-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00277-014-2188-8","article-title":"Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: A single-institution study of 105 Chinese patients","volume":"94","author":"Xu","year":"2015","journal-title":"Ann Hematol"},{"key":"key20200714091613_b39-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"key":"key20200714091613_b40-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1002\/hed.25188","article-title":"Nuclear nonmetastatic protein 23-H1 expression and epithelial-mesenchymal transition in laryngeal carcinoma: A pilot investigation","volume":"40","author":"Marioni","year":"2018","journal-title":"Head Neck"},{"key":"key20200714091613_b41-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"15597","DOI":"10.4238\/2015.December.1.11","article-title":"Correlation between non-metastatic protein 23 expression and clinicopathological features of colorectal cancer in Asians","volume":"14","author":"Fu","year":"2015","journal-title":"Genet Mol Res"},{"key":"key20200714091613_b42-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.gdata.2017.10.006","article-title":"Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC)","volume":"14","author":"Yuan","year":"2017","journal-title":"Genom Data"},{"key":"key20200714091613_b43-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.gene.2018.01.003","article-title":"Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis","volume":"647","author":"Piao","year":"2018","journal-title":"Gene"},{"key":"key20200714091613_b44-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejrad.2018.07.024","article-title":"Value of [18F]FDG PET radiomic features and VEGF expression in predicting pelvic lymphatic metastasis and their potential relationship in early-stage cervical squamous cell carcinoma","volume":"106","author":"Li","year":"2018","journal-title":"Eur J Radiol"},{"key":"key20200714091613_b45-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.currproblcancer.2016.11.007","article-title":"Prognostic and clinicopathological value of NM23 expression in patients with breast cancer: A systematic review and meta-analysis","volume":"41","author":"Han","year":"2017","journal-title":"Curr Probl Cancer"},{"key":"key20200714091613_b46-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1046\/j.1365-2141.2003.04668.x","article-title":"Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma","volume":"123","author":"Niitsu","year":"2003","journal-title":"Br J Haematol"},{"key":"key20200714091613_b47-ol-0-0-10703","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1200\/JCO.2006.09.4474","article-title":"Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas","volume":"25","author":"Cuadros","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T09:55:55Z","timestamp":1594720555000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2019.10703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":47,"URL":"https:\/\/doi.org\/10.3892\/ol.2019.10703","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,2]]}}}